Nicolás Guzmán

2.1k total citations · 1 hit paper
36 papers, 1.5k citations indexed

About

Nicolás Guzmán is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Nephrology. According to data from OpenAlex, Nicolás Guzmán has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 8 papers in Nephrology. Recurrent topics in Nicolás Guzmán's work include Nitric Oxide and Endothelin Effects (9 papers), Potassium and Related Disorders (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Nicolás Guzmán is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Potassium and Related Disorders (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Nicolás Guzmán collaborates with scholars based in United States, United Kingdom and Sweden. Nicolás Guzmán's co-authors include L. Judson Chandler, Fulton T. Crews, Chagriya Kitiyakara, Dominic S. Raj, L C Garg, Harold I. Feldman, Maria R. Wing, Julie R. Ingelfinger, John W. Kusek and Shiow‐Shih Tang and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Kidney International.

In The Last Decade

Nicolás Guzmán

33 papers receiving 1.5k citations

Hit Papers

Association between Albuminuria, Kidney Function, and Inf... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolás Guzmán United States 19 417 391 319 310 224 36 1.5k
Rainer Büscher Germany 23 380 0.9× 555 1.4× 356 1.1× 209 0.7× 312 1.4× 66 1.6k
Miroslaw Smogorzewski United States 23 592 1.4× 477 1.2× 220 0.7× 357 1.2× 227 1.0× 87 1.8k
Robert M. Rosa United States 17 242 0.6× 291 0.7× 286 0.9× 349 1.1× 474 2.1× 31 1.7k
Anna Witasp Sweden 22 528 1.3× 352 0.9× 288 0.9× 169 0.5× 160 0.7× 49 1.5k
Andrzej Książek Poland 22 396 0.9× 340 0.9× 113 0.4× 313 1.0× 111 0.5× 138 1.4k
N.D. Vaziri United States 25 474 1.1× 229 0.6× 272 0.9× 182 0.6× 198 0.9× 93 1.9k
Sandor Falk United States 30 670 1.6× 779 2.0× 298 0.9× 220 0.7× 527 2.4× 53 2.1k
Naoki Ikegaya Japan 19 388 0.9× 179 0.5× 211 0.7× 135 0.4× 138 0.6× 90 1.2k
Yohei Doi Japan 23 229 0.5× 241 0.6× 335 1.1× 303 1.0× 218 1.0× 76 1.7k
Karen Mackay United States 18 436 1.0× 454 1.2× 127 0.4× 203 0.7× 110 0.5× 37 1.5k

Countries citing papers authored by Nicolás Guzmán

Since Specialization
Citations

This map shows the geographic impact of Nicolás Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Guzmán more than expected).

Fields of papers citing papers by Nicolás Guzmán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Guzmán. The network helps show where Nicolás Guzmán may publish in the future.

Co-authorship network of co-authors of Nicolás Guzmán

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás Guzmán. A scholar is included among the top collaborators of Nicolás Guzmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás Guzmán. Nicolás Guzmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mark, Patrick B., Anna L. Eriksson, Maria Leonsson‐Zachrisson, et al.. (2025). Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial. Nephrology Dialysis Transplantation. 40(12). 2280–2288. 2 indexed citations
2.
Fishbane, Steven, Laura M. Dember, Michel Jadoul, et al.. (2025). The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis. Kidney International. 108(4). 686–694.
5.
Fishbane, Steven, Martin L. Ford, Masafumi Fukagawa, et al.. (2022). Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients. Kidney International Reports. 7(4). 908–912.
6.
Fishbane, Steven, Martin L. Ford, Masafumi Fukagawa, et al.. (2022). Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC Nephrology. 23(1). 59–59. 7 indexed citations
7.
Ford, Martin L., Steven Fishbane, Bruce Spinowitz, et al.. (2021). Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia. Kidney International Reports. 6(12). 3074–3078. 4 indexed citations
8.
Hao, Chuan‐Ming, et al.. (2021). Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China. International Journal of Nephrology and Renovascular Disease. Volume 14. 53–64. 7 indexed citations
9.
Wing, Maria R., Joe Devaney, Marshall M. Joffe, et al.. (2014). DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC Study. Nephrology Dialysis Transplantation. 29(4). 864–872. 109 indexed citations
10.
Gupta, Jayanta, Nandita Mitra, Peter A. Kanetsky, et al.. (2012). Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC. Clinical Journal of the American Society of Nephrology. 7(12). 1938–1946. 440 indexed citations breakdown →
11.
Guzmán, Nicolás. (2012). Epidemiology and Management of Hypertension in the Hispanic Population. American Journal of Cardiovascular Drugs. 12(3). 165–178. 28 indexed citations
12.
Raj, Dominic S., et al.. (2012). Renal Failure: Implications of Chronic Kidney Disease in the Management of the Diabetic Foot. Seminars in Vascular Surgery. 25(2). 82–88. 27 indexed citations
13.
Guzmán, Nicolás. (2004). Building a semantic web for securing the homeland. IEEE Engineering in Medicine and Biology Magazine. 23(1). 71–80. 1 indexed citations
14.
Chawla, Lakhmir S., et al.. (2001). Hemodialysis central venous catheter tip fracture with embolization into the pulmonary artery. American Journal of Kidney Diseases. 38(6). 1311–1315. 15 indexed citations
15.
Guzmán, Nicolás, et al.. (2000). A non-nucleotide–bridged DNA decoy inhibits renal epithelial nitric oxide synthase expression. Kidney International. 57(1). 83–91. 10 indexed citations
16.
Kitiyakara, Chagriya & Nicolás Guzmán. (1998). Malignant hypertension and hypertensive emergencies.. Journal of the American Society of Nephrology. 9(1). 133–142. 94 indexed citations
17.
Chandler, L. Judson, et al.. (1995). NF-κB and transcriptional control of renal epithelial-inducible nitric oxide synthase. Kidney International. 48(3). 674–682. 41 indexed citations
18.
Davda, Rajesh K., L. Judson Chandler, & Nicolás Guzmán. (1994). Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. European Journal of Pharmacology Molecular Pharmacology. 266(3). 237–244. 43 indexed citations
19.
Guzmán, Nicolás & Fulton T. Crews. (1992). Regulation of inositol transport by glucose and protein kinase C in mesangial cells. Kidney International. 42(1). 33–40. 23 indexed citations
20.
Halushka, Perry V., et al.. (1992). Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets. European Journal of Pharmacology Molecular Pharmacology. 227(1). 71–78. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026